77 related articles for article (PubMed ID: 26241018)
1. Fibrosis: GLI2 inhibition reduces myofibroblast generation and kidney fibrosis.
Carney EF
Nat Rev Nephrol; 2015 Oct; 11(10):568. PubMed ID: 26241018
[No Abstract] [Full Text] [Related]
2. Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.
Kramann R; Fleig SV; Schneider RK; Fabian SL; DiRocco DP; Maarouf O; Wongboonsin J; Ikeda Y; Heckl D; Chang SL; Rennke HG; Waikar SS; Humphreys BD
J Clin Invest; 2015 Aug; 125(8):2935-51. PubMed ID: 26193634
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
[TBL] [Abstract][Full Text] [Related]
4. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
[TBL] [Abstract][Full Text] [Related]
5. The loss of Krüppel-like factor 15 in Foxd1
Gu X; Mallipattu SK; Guo Y; Revelo MP; Pace J; Miller T; Gao X; Jain MK; Bialkowska AB; Yang VW; He JC; Mei C
Kidney Int; 2017 Nov; 92(5):1178-1193. PubMed ID: 28651950
[TBL] [Abstract][Full Text] [Related]
6. Role of GLI2 in the growth of human osteosarcoma.
Nagao H; Ijiri K; Hirotsu M; Ishidou Y; Yamamoto T; Nagano S; Takizawa T; Nakashima K; Komiya S; Setoguchi T
J Pathol; 2011 Jun; 224(2):169-79. PubMed ID: 21506130
[TBL] [Abstract][Full Text] [Related]
7. Diverse origins of the myofibroblast—implications for kidney fibrosis.
Falke LL; Gholizadeh S; Goldschmeding R; Kok RJ; Nguyen TQ
Nat Rev Nephrol; 2015 Apr; 11(4):233-44. PubMed ID: 25584804
[TBL] [Abstract][Full Text] [Related]
8. GLI2 is a novel therapeutic target for metastasis of osteosarcoma.
Nagao-Kitamoto H; Nagata M; Nagano S; Kitamoto S; Ishidou Y; Yamamoto T; Nakamura S; Tsuru A; Abematsu M; Fujimoto Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S; Setoguchi T
Int J Cancer; 2015 Mar; 136(6):1276-84. PubMed ID: 25082385
[TBL] [Abstract][Full Text] [Related]
9. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
10. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis: the source of myofibroblasts in kidney fibrosis.
Allison SJ
Nat Rev Nephrol; 2013 Sep; 9(9):494. PubMed ID: 23877590
[No Abstract] [Full Text] [Related]
12. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
13. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
15. Baicalein ameliorates renal interstitial fibrosis by inducing myofibroblast apoptosis in vivo and in vitro.
Wang W; Zhou PH; Xu CG; Zhou XJ; Hu W; Zhang J
BJU Int; 2016 Jul; 118(1):145-52. PubMed ID: 26178456
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
[TBL] [Abstract][Full Text] [Related]
17. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Hedgehog signaling pathway impedes cancer cell proliferation by promotion of autophagy.
Tang X; Deng L; Chen Q; Wang Y; Xu R; Shi C; Shao J; Hu G; Gao M; Rao H; Luo S; Lu Q
Eur J Cell Biol; 2015 May; 94(5):223-33. PubMed ID: 25824057
[TBL] [Abstract][Full Text] [Related]
20. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
